头颈部特应性皮炎的诊疗研究进展

doi:10.35541/cjd.20230562

中华皮肤科杂志 ›› 2024, e20230562.doi: 10.35541/cjd.20230562

头颈部特应性皮炎的诊疗研究进展

李芳¹,林颖²

¹广州中医药大学第二临床医学院，广州 510006 ；²广东省中医院皮肤科广东省中医皮肤临床医学研究中心广东省中医药防治难治性慢病重点实验室，广州 510120

收稿日期:2023-09-26 修回日期:2023-12-29 发布日期:2024-05-08
通讯作者: 林颖 E-mail:lin19791226@gzucm.edu.cn
基金资助:
国家自然科学基金（31972856）；广东省中医药防治难治性慢病重点实验室开放课题（MB2020KF05）；广东省省级科技计划项目（2020B1111170012）；广东省中医院拔尖人才项目（BJ2022YL08）；陈达灿全国名老中医药专家传承工作室建设项目（国中医药人教函〔2022〕75号）

Diagnosis and treatment of atopic dermatitis of the head and neck

Li Fang¹, Lin Ying²

¹The Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; ²Department of Dermatology, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Clinical Research Center for Chinese Medicine Dermatology, Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou 510120, China

Received:2023-09-26 Revised:2023-12-29 Published:2024-05-08
Contact: Lin Ying E-mail:lin19791226@gzucm.edu.cn
Supported by:
National Natural Science Foundation of China （31972856）; Open Project of Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases （MB2020KF05）; Guangdong Provincial Science and Technology Planning Project （2020B1111170012）; Top Talents Project of Guangdong Provincial Hospital of Chinese Medicine （BJ2022YL08）; National Famous Old Chinese Medicine Experts Inheritance Studio Construction Project （Chinese Medicine Education Letter ［2022］ No.75）

摘要/Abstract

摘要： 【摘要】特应性皮炎是一种慢性复发性炎症性皮肤病，具有部位异质性，头颈部特应性皮炎作为一个特殊亚型越来越受到关注。本文从病因与发病机制、临床表现、辅助检查、诊断与鉴别诊断、治疗与管理方面介绍头颈部特应性皮炎的研究进展，为临床诊治提供新思路。

关键词: 皮炎, 特应性, 头颈部皮炎, 马拉色菌, 度普利尤单抗, 治疗

Abstract: 【Abstract】 Atopic dermatitis is a chronic relapsing inflammatory dermatosis with heterogeneity at different body sites. Atopic dermatitis of the head and neck has received increasing attention as a special-site subtype. This review summarizes the research progress in atopic dermatitis of the head and neck from the aspects of etiology and pathogenesis, clinical manifestations, auxiliary examinations, diagnosis and differential diagnosis, as well as treatment and management, aiming to provide new ideas for its clinical diagnosis and treatment.

Key words: Dermatitis, atopic, Head-and-neck dermatitis, Malassezia, Dupilumab, Treatment

李芳林颖. 头颈部特应性皮炎的诊疗研究进展[J]. 中华皮肤科杂志, 2024,e20230562. doi:10.35541/cjd.20230562

Li Fang, Lin Ying. Diagnosis and treatment of atopic dermatitis of the head and neck[J]. Chinese Journal of Dermatology,2024,e20230562. doi:10.35541/cjd.20230562

参考文献 40

［1］	Bax CE, Khurana MC, Treat JR, et al. New⁃onset head and neck dermatitis in adolescent patients after dupilumab therapy for atopic dermatitis［J］. Pediatr Dermatol, 2021,38（2）:390⁃394. doi: 10.1111/pde.14499.
［2］	Guglielmo A, Sechi A, Patrizi A, et al. Head and neck dermatitis, a subtype of atopic dermatitis induced by Malassezia spp: clinical aspects and treatment outcomes in adolescent and adult patients［J］. Pediatr Dermatol, 2021,38（1）:109⁃114. doi: 10.1111/ pde.14437.
［3］	Chu H, Kim SM, Zhang K, et al. Head and neck dermatitis is exacerbated by Malassezia furfur colonization, skin barrier disruption, and immune dysregulation［J］. Front Immunol, 2023,14:1114321. doi: 10.3389/fimmu.2023.1114321.
［4］	Dirschka T, Szliska C, Jackowski J, et al. Impaired skin barrier and atopic diathesis in perioral dermatitis［J］. J Dtsch Dermatol Ges, 2003,1（3）:199⁃203. doi: 10.1046/j.1610⁃0387.2003. 02039.x.
［5］	林洁, 杨连娟, 杨名珍. 头颈部特应性皮炎患者面部马拉色菌的菌种分布［J］. 中国真菌学杂志, 2021,16（3）:161⁃165. doi: 10.3969/j.issn.1673⁃3827.2021.03.004.
［6］	Zheng Y, Wang Q, Ma L, et al. Alterations in the skin microbiome are associated with disease severity and treatment in the perioral zone of the skin of infants with atopic dermatitis［J］. Eur J Clin Microbiol Infect Dis, 2019,38（9）:1677⁃1685. doi: 10.1007/s10096⁃019⁃03598⁃9.
［7］	Uchida H, Kamata M, Egawa S, et al. Newly developed erythema and red papules in the face and neck with detection of demodex during dupilumab treatment for atopic dermatitis improved by discontinuation of dupilumab, switching to upadacitinib or treatment with oral ivermectin: a report of two cases［J］. J Eur Acad Dermatol Venereol, 2023,37（3）:e300⁃e302. doi: 10.1111/jdv.18743.
［8］	Muzumdar S, Skudalski L, Sharp K, et al. Dupilumab facial redness/dupilumab facial dermatitis: a guide for clinicians［J］. Am J Clin Dermatol, 2022,23（1）:61⁃67. doi: 10.1007/s40257⁃021⁃00646⁃z.
［9］	Mayser P, Kupfer J, Nemetz D, et al. Treatment of head and neck dermatitis with ciclopiroxolamine cream⁃⁃results of a double⁃blind, placebo⁃controlled study［J］. Skin Pharmacol Physiol, 2006,19（3）:153⁃158. doi: 10.1159/000092596.
［10］	Patruno C, Ferrillo M, Fabbrocini G, et al. A case of dirty neck in severe and diffuse atopic dermatitis successfully treated with dupilumab［J］. Dermatol Ther, 2021,34（1）:e14556. doi: 10. 1111/dth.14556.
［11］	Woo YR, Cho M, Han Y, et al. Characterization of distinct microbiota associated with scalp dermatitis in patients with atopic dermatitis［J］. J Clin Med, 2022,11（6）. doi: 10.3390/jcm11061735.
［12］	de Wijs L, Nguyen NT, Kunkeler A, et al. Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series［J］. Br J Dermatol, 2020,183（4）:745⁃749. doi: 10.1111/bjd.18730.
［13］	Kozera E, Stewart T, Gill K, et al. Dupilumab⁃associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia⁃specific IgE: a multicentre, prospective cohort study［J］. Br J Dermatol, 2022,186（6）:1050⁃1052. doi: 10.1111/bjd.21019.
［14］	Kozera E, Flora A, Stewart T, et al. Dupilumab⁃associated head and neck dermatitis resolves temporarily with itraconazole therapy and rapidly with transition to upadacitinib, with Malassezia⁃specific immunoglobulin E levels mirroring clinical response［J］. J Am Acad Dermatol, 2023,88（1）:255⁃257. doi: 10.1016/j.jaad.2022.05.021.
［15］	Liane JG, Morgado⁃Carrasco D. Dupilumab⁃associated facial erythema successfully treated with oral ivermectin［J］. Dermatol Pract Concept, 2022,12（4）:e2022184. doi: 10.5826/dpc.1204a184.
［16］	Navarro⁃Triviño FJ, Vega⁃Castillo JJ, Llamas⁃Molina JM, et al. Refractory head and neck atopic dermatitis pattern treated with dupilumab: allergic contact dermatitis caused by decyl glucoside. Should surfactants be patched?［J］. Australas J Dermatol, 2021,62（4）:509⁃511. doi: 10.1111/ajd.13678.
［17］	Napolitano M, Fabbrocini G, Patruno C. Allergic contact dermatitis to compositae: a possible cause of dupilumab⁃associated facial and neck dermatitis in atopic dermatitis patients?［J］. Contact Dermatitis, 2021,85（4）:473⁃474. doi: 10. 1111/cod.13898.
［18］	Gao H, Zhang Z, Ma L, et al. Photosensitivity is an important cause of refractory facial erythema in atopic dermatitis: a retrospective study of 82 Chinese patients［J］. Photodermatol Photoimmunol Photomed, 2023,39（4）:318⁃324. doi: 10.1111/phpp.12836.
［19］	中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心. 中国特应性皮炎诊疗指南（2020版）［J］. 中华皮肤科杂志, 2020,53（2）:81⁃88. doi: 10.35541/cjd.20191000.
［20］	中华医学会皮肤性病学分会免疫学组. 特应性皮炎的全程管理共识［J］. 中华皮肤科杂志, 2023,56（1）:5⁃15. doi: 10.35541/cjd.20220618.
［21］	Kachiu C, Dennis W, Jaimee H, et al. Novel use of a cooling pillow for treatment of severe head and neck atopic dermatitis［J］.Retour au numéro, 2013,68（4）:AB77. doi: https://doi.org/10.1016/ j.jaad.2012.12.319
［22］	中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组, 中华医学会皮肤性病学分会儿童学组, 中国老年保健医学研究会皮肤科分会. 特应性皮炎外用制剂合理应用及患者指导专家共识［J］. 中华皮肤科杂志, 2022,55（4）:281⁃288. doi: 10.35541/cjd.20210833.
［23］	Wollenberg A, Kinberger M, Arents B, et al. European guideline （EuroGuiDerm） on atopic eczema ⁃ partⅡ: non⁃systemic treatments and treatment recommendations for special AE patient populations［J］. J Eur Acad Dermatol Venereol, 2022,36（11）:1904⁃1926. doi: 10.1111/jdv.18429.
［24］	中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组, 中华医学会皮肤性病学分会儿童学组. 特应性皮炎湿包疗法临床应用专家共识［J］. 中华皮肤科杂志, 2022,55（4）:289⁃294. doi: 10.35541/cjd.20210823.
［25］	Sidbury R, Alikhan A, Bercovitch L, et al. Guidelines of care for the management of atopic dermatitis in adults with topical therapies［J］. J Am Acad Dermatol, 2023,89（1）:e1⁃e20. doi: 10.1016/j.jaad.2022.12.029.
［26］	Tsai YC, Tsai TF. Facial erythema during dupilumab treatment for atopic dermatitis successfully remedied with topical crisaborole ointment: a case report［J］. Dermatol Ther, 2022,35（11）:e15843. doi: 10.1111/dth.15843.
［27］	Miyagaki T, Okano T, Nakajima K, et al. A case of facial redness in atopic dermatitis occurring during dupilumab treatment successfully treated with topical delgocitinib ointment［J］. Dermatol Ther, 2021,34（2）:e14888. doi: 10.1111/dth.14888.
［28］	Simpson EL, Paller AS, Siegfried EC, et al. Dupilumab demonstrates rapid and consistent improvement in extent and signs of atopic dermatitis across all anatomical regions in pediatric patients 6 years of age and older［J］. Dermatol Ther （Heidelb）, 2021,11（5）:1643⁃1656. doi: 10.1007/s13555⁃021⁃00568⁃y.
［29］	Ahn J, Lee DH, Na CH, et al. Facial erythema in patients with atopic dermatitis treated with dupilumab ⁃ a descriptive study of morphology and aetiology［J］. J Eur Acad Dermatol Venereol, 2022,36（11）:2140⁃2152. doi: 10.1111/jdv.18327.
［30］	中华医学会皮肤性病学分会特应性皮炎研究中心, 中华医学会皮肤性病学分会儿童学组. 度普利尤单抗治疗特应性皮炎专家共识［J］. 中华皮肤科杂志, 2022,55（6）:465⁃470. doi: 10. 35541/cjd.20210885.
［31］	Wollenberg A, Lio P, Kleyn E, et al. Improvement of head and neck symptoms in patients with atopic dermatitis treated with baricitinib based on five phaseⅢ clinical trials［J］. Eur J Dermatol, 2022,32（4）:522⁃529. doi: 10.1684/ejd.2022.4280.
［32］	Alexis A, de Bruin⁃Weller M, Weidinger S, et al. Rapidity of improvement in signs/symptoms of moderate⁃to⁃severe atopic dermatitis by body region with abrocitinib in the phase 3 JADE COMPARE Study［J］. Dermatol Ther （Heidelb）, 2022,12（3）:771⁃785. doi: 10.1007/s13555⁃022⁃00694⁃1.
［33］	陈教全, 余南极, 高爱莉, 等. 乌帕替尼治疗度普利尤单抗抵抗的面颈部特应性皮炎患者1例［J/OL］. 中国皮肤性病学杂志: 1⁃4［2023⁃12⁃28］. doi: 10.13735/j.cjdv.1001⁃7089.2023 01016.
［34］	Jang YK, Kim DH, Yoon MS, et al. Development of desquamation with Staphylococcus aureus colonization in patients with atopic dermatitis under treatment with upadacitinib［J］. Clin Exp Dermatol, 2023,48（3）:240⁃242. doi: 10.1093/ced/llac068.
［35］	Samia AM, Cuervo⁃Pardo L, Montanez⁃Wiscovich ME, et al. Dupilumab⁃associated head and neck dermatitis with ocular involvement in a ten⁃year⁃old with atopic dermatitis: a case report and review of the literature［J］. Cureus, 2022,14（7）:e27170. doi: 10.7759/cureus.27170.
［36］	Ordóñez⁃Rubiano MF, Casas M, Balaguera⁃Orjuela V. Dupilumab facial redness: clinical characteristics and proposed treatment in a cohort［J］. Dermatol Ther, 2021,34（6）:e15140. doi: 10.1111/dth.15140.
［37］	Chen M, Gao K, Ali K, et al. Case report: dupilumab leads to an increased chance of head and neck Staphylococcus aureus infection in atopic dermatitis patients［J］. Front Med （Lausanne）, 2023,10:1027589. doi: 10.3389/fmed.2023.1027589.
［38］	Murase JE, Chovatiya R, Strowd L, et al. 381 improved and cleared facial and hand dermatitis with lebrikizumab in patients with moderate⁃to⁃severe atopic dermatitis［J］. British Journal of Dermatology, 2023,188（Supplement_3）:ljad162.009. doi: 10.1093/ bjd/ljad162.009.
［39］	Labib A, Ju T, Yosipovitch G. Managing atopic dermatitis with lebrikizumab ⁃ the evidence to date［J］. Clin Cosmet Investig Dermatol, 2022,15:1065⁃1072. doi: 10.2147/CCID.S295672.
［40］	Head, neck dermatitis improved with rocatinlimab \| Mount Sinai ⁃ New York［EB/OL］. Mount Sinai Health System. （2023⁃07⁃18）. https://www.mountsinai.org/about/newsroom/2022/head⁃neck⁃dermatitis⁃improved⁃with⁃rocatinlimab.

[1]	中国康复医学会皮肤病康复专业委员会中国中西医结合学会皮肤性病专业委员会老年皮肤病学组. [开放获取] 老年皮肤瘙痒症诊疗与康复专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 58(1): 1-8.
[2]	中国康复医学会皮肤病康复专业委员会中国康复医学会光动力治疗与康复专业委员会中华医学会皮肤性病学分会光动力治疗协作组. [开放获取] 氨基酮戊酸光动力疗法治疗非黑色素瘤皮肤癌临床应用专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 58(1): 9-19.
[3]	廖彩荷王佩茹吴明顺孙晓飞张国龙王秀丽. 联合氨基酮戊酸光动力疗法治疗老年颜面部基底细胞癌的疗效及安全性回顾分析[J]. 中华皮肤科杂志, 2025, 58(1): 34-39.
[4]	金兰邱云王唯嘉康晓静丁媛. [开放获取] 生物制剂治疗老年中重度银屑病124例的临床疗效和安全性回顾分析[J]. 中华皮肤科杂志, 2025, 58(1): 47-52.
[5]	王博郑捷. 老年银屑病和特应性皮炎患者生物制剂及小分子药物治疗中应注意的问题[J]. 中华皮肤科杂志, 2025, 58(1): 72-75.
[6]	杨子靖陈利红阮叶平文莞廷张嘉艺王海伦潘萌赵肖庆. 度普利尤单抗治疗老年性特应性皮炎的疗效及安全性研究[J]. 中华皮肤科杂志, 2025, 58(1): 65-69.
[7]	王迪张瑞珺康玉英. 脂溢性皮炎的发病机制及治疗研究进展[J]. 中华皮肤科杂志, 2025, 58(1): 89-92.
[8]	王瑞霞曲岩磊艾文锦闫琳曲才杰史同新. 非大疱性嗜中性红斑狼疮1例[J]. 中华皮肤科杂志, 2024, 57(9): 832-834.
[9]	向茜张凌燕钟琳高奕邱逦. 鲜红斑痣多模态超声表现及在光动力疗效评估中的应用研究[J]. 中华皮肤科杂志, 2024, 57(9): 801-806.
[10]	乔嘉熙夏萍陈柳青. 司库奇尤单抗治疗前后银屑病局部皮损皮肤镜和反射式共聚焦显微镜特征分析[J]. 中华皮肤科杂志, 2024, 57(9): 825-829.
[11]	任伟琦邹雅茹潘敏. 大疱性类天疱疮患者继发感染危险因素的研究进展[J]. 中华皮肤科杂志, 2024, 57(8): 770-772.
[12]	宋雨晴杨楠刘琳琳冯子仪韩世新周梅娟. [开放获取] 皮肤磨削术治疗家族性良性慢性天疱疮6例临床观察[J]. 中华皮肤科杂志, 2024, 57(8): 743-746.
[13]	林子沅庞天怡武静文靳慧. 多环芳烃在炎症性皮肤病发生发展中的作用研究进展[J]. 中华皮肤科杂志, 2024, 57(8): 765-769.
[14]	夏曼琪邵蕾黄琼霄田歆梁毅敏黄婷梁景耀刘玉梅. 度普利尤单抗治疗结节性痒疹疗效与安全性的多中心回顾性分析[J]. 中华皮肤科杂志, 2024, 57(8): 679-684.
[15]	罗莉张博娜吴畏汤文静李岳华刘晓莉马雅楠李翠翠齐梦岩孙妮石琼. [开放获取] 308 nm准分子激光与308 nm准分子光治疗194例儿童白癜风的疗效及安全性回顾分析[J]. 中华皮肤科杂志, 2024, 57(8): 721-727.

头颈部特应性皮炎的诊疗研究进展

Diagnosis and treatment of atopic dermatitis of the head and neck

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 40

相关文章 15

Metrics

本文评价

推荐阅读 10